| 1Norephedrine |
|---|
| 2Norpseudoephedrine |
| 3Phentermine |
| 4Amphetamine-d11 |
| 5Amphetamine |
| 6Ephedrine |
| 7Methamphetamine-d14 |
| 8Methamphetamine |
| 9Pseudoephedrine |
| 10MDA-d5 |
| 11MDA |
| 12MDMA-d5 |
| 13MDMA |
| 14TFMPP |
| 15MDEA-d5 |
| 16MDEA |
search
Applications
Expanded amphetamines and interferences including TFMPP by MSD on a ZB-Drug1
18039
Separation Mode: Application Specific
Application Specific
ZB-Drug-1
GC
Serotonin Agonists
Forensics/Toxicology
Toxicology / Drug Screening / TDM
Therapeutic / Clinical
Analytes
Details
GC Conditions (App ID: 18039)
Column: |
Part No: |
Phase Name: ZB-Drug-1 |
Sample Notes: Analytes are 20ppm derivatized with HFBA
Sim ions:
(Quant ion*) D11-Amphetamine (*244,128): Amphetamine (*240,118,117): D14-Methamphetamine (*261,213): Methamphetamine (*254,210,118): D5-MDA (*167,380,244): MDA (*162,375,240): D5-MDMA (*258,213,164): MDMA (*254,210,389): D5-MDEA (*273,241,408): MDEA (*268,240,403)
Note: Amphetamine-d11 does not share ions with coeluting interferences. |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.